Simpler, one-dose treatment to prevent malaria relapse OK’d
On July 20, 2018, the U.S. Food and Drug Administration approved GlaxoSmithKline’s Krintafel, a simpler, one-dose treatment, to prevent relapses of malaria.Associated Press file Standard treatment now takes two weeks…
